Thursday's daily short sale volume was 31.36% (as reported by FINRA) and the shorts managed to get the PPS down with their heavy manipulations. However, the short borrow fee is up to 103.91% and the short shares availability came down from more than a million shares to 400 shares that are currently available! With all the expected news coming in from EMA, MHRA, Health Canada and FDA, it should just be a matter of time until Multikine will be approved and the heavy manipulation by the shorts will come to an end. To keep the PPS low, the shorts have increased their position by another 230'000 to currently 8.46 million shorted shares (short float of 16.13%). I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!! Tick tock, tick tock...

Yesterday's daily short sale volume was 22.30% (as reported by FINRA) but despite all the heavy manipulations by the shorts, the PPS went up 14.5%. The short borrow fee is up to 81.71% and the short shares availability came down from more than a million shares to 40'000 shares that are currently available! With all the expected news coming in from EMA, MHRA, Health Canada and FDA, it should just be a matter of time until Multikine will be approved and the heavy manipulation by the shorts will come to an end. To keep the PPS low, the shorts have increased their position by another 200'000 to currently 8.21 million shorted shares (short float of 15.66%) - up almost 1 million shares since last month. I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!! Tick tock, tick tock...

Friday's daily short sale volume was 55.72% (as reported by FINRA) but despite all the heavy manipulations by the shorts, the PPS went up 10.00%. The short borrow fee went up to 85.44% and the short shares availability came down from more than a million shares to only 2000 shares that are currently available! With all the expected news coming in from EMA, MHRA, Health Canada and FDA, it should just be a matter of time until Multikine will be approved and the heavy manipulation by the shorts will come to an end. To keep the PPS low, the shorts have increased their position to currently 8.04 million shorted shares (short float of 15.33%) - up almost 1 million shares since last month. I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!! Tick tock, tick tock...

Tuesday's daily short sale volume was 69.64% (as reported by FINRA) but despite all the manipulations by the shorts, the PPS went up 3.97%! The short borrow fee went up to 13.90% and the short shares availability came down from more than a million to 15'000! With all the facts and clarifications that we got in the latest Letter to Shareholders and the news coming in from EMA, MHRA, Health Canada and FDA, it should just be a matter of time until Multikine will be approved and the heavy manipulation by the shorts will come to an end. To keep the PPS low, the shorts still have a position of currently 6.7 million shorted shares (short float of 12.75%). I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!! Tick tock, tick tock...

Yesterday's daily short sale volume was 68.62% (as reported by FINRA) but despite all the manipulations by the shorts, the PPS went up 0.56%! The short borrow fee is still at 13.28%! With all the facts and clarifications that we got in the latest Letter to Shareholders and the news coming in from EMA, MHRA, Health Canada and FDA, it should just be a matter of time until Multikine will be approved and the heavy manipulation by the shorts will come to an end. To keep the PPS low, the shorts still have a position of currently 6.97 million shorted shares (short float of 13.34%). The CEO promises us an interesting month: "We are looking forward to a month filled with several very important meetings designed to bring our cancer therapy Multikine to market. We will keep you updated on our progress." I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!!

65.88% daily short volume on Monday but PPS up 12%!

5.72 million shares (12.55% of the float) currently shorted
Current borrow fee: 10.45%
Shares available to borrow: 450'000

65.88% of the daily volume has been shorted on Monday (as reported by FINRA) but despite the attacks by the shorts the PPS went up 12%! The number of available shares for shorting is 450'000 and the borrow fee is 10.45% The overall number of shorted shares has increased by 700'000 over the last few weeks - just ask yourself who would short CVM at this stage. The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

63.44% daily short volume on Wednesday and the shorts managed to bring the PPS down 3.03%

5.72 million shares (12.55% of the float) currently shorted
Current borrow fee: 10.44%
Shares available to borrow: 350'000

63.44% of the daily volume has been shorted on Wednesday (as reported by FINRA) and the shorts managed to bring the PPS down 3.03% The number of available shares for shorting is 350'000 and the borrow fee is 10.424! The overall number of shorted shares has increased by 700'000 over the last few weeks - just ask yourself who would short CVM at this stage. The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

70.92% Daily Short Volume but PPS up 2.67%!

70.92% of the daily volume has been shorted on Friday (as reported by FINRA) but the PPS went up 2.67%! The number of available shares for shorting is 90'000 and the borrow fee is 11.1%! The short volume has come down more than 1 million shares from 6.04 million to 4.97 million shares over the last month and it seems that the shorts are covering under the radar. The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

And here are two quotes from Geert Kersten's latest interview with Global Market Bulletin TV in May:

"It's all about bringing the drug to market. The beautiful thing is this: we're very much de-risked. Right, the big risk in a biotech company is, you know what will the data show. Will the drug even work? Well, you see it very clearly — it's multi-years of life extension, right. Tumours going away. And no toxicities, no safety issues. So that's been de-risked — all you have to be thinking about is will this drug come to market and by which pathway."

"The Canadians gave us the path. The Canadians said, we understand that there's great benefit for these patients. We also see your study is different from anything we've seen before, so conditional is the best way to go. The European regulations, I mean I have them here, I'm not going to bother reading them to you, but you have to show that risk-benefit balance of the medicine is positive, that you can do follow-on studies, that it's an unmet medical need and that the medicine's immediate availability to patients is greater than the risk inherent in the fact that additional data is needed. It seems obvious to me that we fit all of those requirements too."

Latest Interview With Geert Kersten

38.22% daily short volume but PPS up 8.33%!!

12.88% institutional ownership
6.04 million shares (14.35% of the float) currently shorted
Current borrow fee: 11.3%
Shares available to borrow: 90'000

38.22% of the daily volume has been shorted on Monday (as reported by FINRA) but the PPS went up 8.33%! The number of currently shorted shares increased again and is now over 6 million shares - will be fun to watch the shorts trying to cover as more positive news come in. The number of available shares for shorting is 90'000 and the borrow fee is 11.3%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

55.57% daily short volume on Tuesday but PPS up 4%!!

13.46% institutional ownership
5.59 million shares (13.29% of the float) currently shorted
Current borrow fee: 11.3%
Shares available to borrow: 100'000

55.57% of the daily volume has been shorted on Tuesday (as reported by FINRA) but the PPS went up 4%! The number of available shares for shorting is 100'000 and the borrow fee is 11.3%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

84.26% daily short volume on Thursday!!

13.95% institutional ownership
5.59 million shares (13.29% of the float) currently shorted
Current borrow fee: 11.6 %
Shares available to borrow: 15'000

An unbelievable 84.26% of the daily volume has been shorted on Thursday (as reported by FINRA) — it seems that the desperate shorts are hard at work! The number of available shares for shorting is 15'000 and the borrow fee is 11.6! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

Latest presentation: Multikine (Leukocyte Interleukin, Inj.) Cancer Immunotherapy: Activating the immune system of cancer patients before surgery and radiation and creating a non-toxic cancer drug (April 2023)

61.50% daily short volume on Friday!!

13.56% institutional ownership
5.56 million shares (13.23% of the float) currently shorted
Current borrow fee: 10.9 %
Shares available to borrow: 35'000

A very high 61.50% of the daily volume has been shorted on Friday (as reported by FINRA) but despite the heavy efforts of the shorts, the PPS did not go down! The number of available shares for shorting is 35'000 and the borrow fee is 10.9%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

Upcoming FDA Filing

The following can be found in an article on 'New Research Released on CEL-SCI Corporation' (https://www.crystalra.com/blog/cel-sci-1):

"Upcoming FDA Filing
CEL-SCI has met with the FDA and received their questions and comments. The Company expects to submit a major follow-up package to the FDA very soon, addressing any of its questions or comments. CEL-SCI also expects to file the Clinical Study Report, which is typically filed with a Biologics License Application (BLA). CEL-SCI’s treatment is novel and its data is extensive and solid. The Company has been able to identify with high accuracy the patients who are most likely to have great overall survival benefit from Multikine®, which includes over 210,000 patients per year globally. CEL-SCI also continues to validate its manufacturing facility to ensure it will follow the standards for a BLA approval."

62.74% daily short volume but PPS up 4.15%!!

13.56% institutional ownership
5.33 million shares (12.69% of the float) currently shorted
Current borrow fee: 10.5 %
Shares available to borrow: 45'000

A very high 62.74% of the daily volume has been shorted on Friday (as reported by FINRA) but despite the heavy efforts of the shorts, the PPS went up 4.15%! The number of available shares for shorting is 45'000 and the borrow fee is 10.5%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

66.86% daily short volume today but PPS up 26.5%!!

13.56% institutional ownership
5.13 million shares (12.19% of the float) currently shorted
Current borrow fee: 10.1 %
Shares available to borrow: 20'000

A very high 66.86% of the daily volume has been shorted today (as reported by FINRA) but despite the heavy efforts of the shorts, the PPS went up 26.5%! The number of available shares for shorting is 20'000 and the borrow fee is 10.1%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! New phase 3 data is going to be presented at the 10th European Congress on Head & Neck Oncology in Lisbon, Portugal on March 8. GLTAL! Tick tock, tick tock ...

72.79% daily short volume but PPS up 7.80%!!

13.52% institutional ownership
5.13 million shares (12.21% of the float) currently shorted
Current borrow fee: 8.6 %
Shares available to borrow: 100'000

An unbelievable 72.79% of the daily volume has been shorted on Friday (as reported by FINRA) but despite the heavy efforts of the shorts, the PPS went up 7.80%! The number of available shares for shorting is 100'000 and the borrow fee is 8.6%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...

76.78% daily short volume on Friday but PPS up 3.57%!!!

19.03% institutional ownership
76.78% daily short volume on Friday!
5.78 million shares (13.86% of the float) currently shorted
Current borrow fee: 15.5%
Shares available to borrow: 100'000

76.78% of the daily volume has been shorted on Friday but the PPS went up 3.57%!! The number of available shares for shorting is 100'000 and the borrow fee is 15.5% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! Recent interview with Geert Kersten - GLTAL! Tick tock, tick tock ...

75.78% daily short volume but PPS up 4.14%!!!

19.05% institutional ownership
75.78% daily short volume on Thursday but PPS up 4.14%!
6.02 million shares (14.44% of the float) currently shorted
Current borrow fee: 16.2%
Shares available to borrow: 95'000

75.78% of the daily volume has been shorted on Thursday but the PPS went up 4.14%! Why are these highly criminal activities not investigated by the SEC?? The number of available shares for shorting is 95'000 and the borrow fee is 16.2% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! Interview Geert Kersten GLTAL! Tick tock, tick tock ...

84.68% daily short volume on Wednesday!!!

19.68% institutional ownership
84.68%% daily short volume on Wednesday!
6.06 million shares (14.54% of the float) currently shorted
Current borrow fee: 22.7%
Shares available to borrow: 65'000

84.68% of the daily volume has been shorted on Wednesday! How on earth is it possible that these highly criminal activities are not investigated by the SEC?? The number of available shares for shorting is 65'000 and the borrow fee is 22.7% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! CVM is featured in a video on the sick illegal manipulations of short sellers insert-text-here ! GLTAL! Tick tock, tick tock ...

Sick Short Sellers!!
Recent video about the heavy and disgusting manipulations by short sellers:

66.79% daily short volume on Monday!!

19.68% institutional ownership
66.79% daily short volume on Monday!
6.06 million shares (14.54% of the float) currently shorted
Current borrow fee: 17.8%
Shares available to borrow: 45'000 (down from 500'000)

66.79% of the daily volume has been shorted on Monday! The number of available shares for shorting is down from 500'000 to 45'000 (iborrowdesk) and the borrow fee is 17.8% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! A new video with Geert Kersten can be found at insert-text-here! GLTAL! Tick tock, tick tock ...

65.03% daily short volume but PPS up 1.47%!!

19.68% institutional ownership
65.03% daily short volume on Thursday but PPS up 1.47%!
6.06 million shares (14.54% of the float) currently shorted
Current borrow fee: 18.5%
Shares available to borrow: 500'000

65.03% of the daily volume has been shorted on Thursday but the PPS went up 1.47%! 500'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 18.5% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! A new video with Geert Kersten can be found at https://www.youtube.com/watch?app=desktop&v=Pj3TuM1hyu8&feature=youtu.be! GLTAL! Tick tock, tick tock ...

33.38% daily short volume but PPS up 4.08%!!

19.68% institutional ownership
33.38% daily short volume on Thursday but PPS up 4.08%!
6.08 million shares (14.59% of the float) currently shorted
Current borrow fee: 20.3%
Shares available to borrow: 250'000

33.38% of the daily volume has been shorted on Thursday but the PPS went up 5.84%. Only 250'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 20.3% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! A new video with Geert Kersten can be found at https://www.youtube.com/watch?app=desktop&v=Pj3TuM1hyu8&feature=youtu.be! GLTAL! Tick tock, tick tock ...

72.78% daily short volume but PPS up 5.84%!!

19.68% institutional ownership
72.78% daily short volume on Wednesday but PPS up 5.84%!
6.08 million shares (14.59% of the float) currently shorted
Current borrow fee: 21.1%
Shares available to borrow: 400'000

An unbelievable 72.78% of the daily volume has been shorted on Wednesday (sometimes I wonder what the SEC is busy with) and the PPS went up 5.84% - just imagine what will happen to the PPS once the manipulation by the shorts is over!! Only 400'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 21.1% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

46.63% daily short volume but PPS up 2.6%!!

19.68% institutional ownership
46.63% daily short volume on Tuesday but PPS up 2.6%!
6.08 million shares (14.59% of the float) currently shorted
Current borrow fee: 20.9%
Shares available to borrow: 300'000

An unbelievable 46.63% of the daily volume has been shorted on Tuesday (sometimes I wonder what the SEC is busy with) and the PPS went up 2.6% - but the shorts will soon pay for it!! Only 300'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 20.9% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

57.22% daily short volume on Wednesday but PPS up 1.03%!!

19.70% institutional ownership
57.22% daily short volume on Wednesday but PPS up 1.03%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 23.2%
Shares available to borrow: 300'000

An unbelievable 57.22% of the daily volume has been shorted on Wednesday (sometimes I wonder what the SEC is busy with) - but the shorts will soon pay for it!! Only 300'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 23.2% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

48.49% daily short volume on Tuesday!!

19.70% institutional ownership
48.49% daily short volume on Tuesday!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 23.2%
Shares available to borrow: 100'000

An unbelievable 48.49% of the daily volume has been shorted on Tuesday (sometimes I wonder what the SEC is busy with) - but the shorts will soon pay for it!! Only 100'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 23.2% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

52.73% daily short volume on Monday but PPS up 1.02%!!

19.75% institutional ownership
52.73% daily short volume on Monday but PPS up 1.02%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 24.2%
Shares available to borrow: 150'000

An unbelievable 52.73% of the daily volume has been shorted on Monday (sometimes I wonder what the SEC is busy with) - but the shorts will soon pay for it!! Only 150'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 24.2% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear and were cured after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

43.43% daily short volume but PPS up 2.16%!!

19.75% institutional ownership
43.43% daily short volume on Wednesday but PPS up 2.16%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 26.7%
Shares available to borrow: 150'000

An unbelievable 43.43% of the daily volume has been shorted on Wednesday (sometimes I wonder what the SEC is busy with) - but the shorts will soon pay for it!! Only 150'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 26.7% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

50.88% daily short volume on Monday but PPS up 1.37%!!

19.75% institutional ownership
50.88% daily short volume on Monday but PPS up 1.37%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 26.1%
Shares available to borrow: 200'000

An unbelievable 50.88% of the daily volume has been shorted on Monday (sometimes I wonder what the SEC is busy with) - but the shorts will soon pay for it!! Only 200'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 26.1% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

69.00% daily short volume but PPS up 3.79%!!

19.75% institutional ownership
69.00% daily short volume on Friday but PPS up 3.79%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 30.3%
Shares available to borrow: 6'000

An unbelievable 69.00% of the daily volume has been shorted on Friday (sometimes I wonder what the SEC is busy with) - but the shorts will soon pay for it!! Only 6'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 30.3% - as soon as we get some decent volume, the shorts will get a serious problem! The data has been published on ClinicalTrials.gov and confirms that Multikine is a drug with a median extended life expectancy of more than 4 years and zero toxicity. Further, 5 patients had their tumors completely disappear after 3 weeks of Multikine treatment and before surgery!! Let us hope that many cancer patients can soon profit from this revolutionary cancer treatment! GLTAL! Tick tock, tick tock ...

51.46% daily short volume on Wednesday!!

19.75% institutional ownership
51.46% daily short volume on Wednesday but PPS up 25.42%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 30.7%
Shares available to borrow: 100'000

An incredible 51.46% of the daily volume has been shorted on Wednesday - it seems that the shorts are getting desperate! Only 100'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 30.7% - as soon as we get some decent volume, the shorts will get a serious problem! Any day from now we might get some more news and the manipulation by the shorts will finally come to an end! And this is all for Multikine, a drug with a median extended life expectancy of more than 4 years and zero toxicity (5 patients had their tumors completely disappear before surgery!) Let us hope that many cancer patients can soon profit from this revolutionary treatment! GLTAL! At most 1 day until we get some news from clinicaltrials.gov! Tick tock, tick tock ...

49.62% daily short volume but PPS up 25.42%!!

20.42% institutional ownership
49.62% daily short volume on Monday but PPS up 25.42%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 29.4%
Shares available to borrow: 95'000

An incredible 49.62% of the daily volume has been shorted on Monday but the PPS went up 25.42% - it seems that the shorts are getting desperate! Only 95'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 29.4% - as soon as we get some decent volume, the shorts will get a serious problem! Any day from now we might get some more news and the manipulation by the shorts will finally come to an end! And this is all for Multikine, a drug with a median extended life expectancy of more than 4 years and zero toxicity (5 patients had their tumors completely disappear before surgery!) Let us hope that many cancer patients can soon profit from this revolutionary treatment! GLTAL! At most 3 days until we get some news from clinicaltrials.gov! Tick tock, tick tock ...

"Five patients in the study had their tumors completely disappear (confirmed by pathology) before surgery. In the ITT population as a whole, 8.5% of all Multikine-treated patients had a tumor response before surgery, but not a single tumor response before surgery was seen in the ITT control group before surgery, statistically a highly significant finding (p-value of less than 0.00000000001). This indicates that the likelihood of seeing these results by chance is less than 1 in ten billion. These results confirm findings from the Phase 1 and 2 studies with Multikine and provide direct evidence of Multikine’s anticancer activity." GLTAL!! Tick tock, tick tock...

51.81% daily short volume on Friday but PPS went up 4.25%!!

32.66% institutional ownership
51.81% daily short volume on Friday but PPS up 4.25%!
6.48 million shares (15.6% of the float) currently shorted
Current borrow fee: 30.4%
Shares available to borrow: 100'000

An incredible 51.81% of the daily volume has been shorted on Friday but the PPS went up 4.25% - it seems that the shorts are getting desperate every single day! Only 100'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 30.4% - as soon as we get some decent volume, the shorts will get a serious problem! Any day from now we might get some more news and the manipulation by the shorts will finally come to an end! And this is all for Multikine, a drug with a median extended life expectancy of more than 4 years and zero toxicity!! Let us hope that many cancer patients can soon profit from this revolutionary treatment! GLTAL! At most 5 days until we get some news from clinicaltrials.gov! Tick tock, tick tock ...

47.95% daily short volume on Wednesday but PPS not down!

32.66% institutional ownership
47.95% daily short volume on Wednesday!
6.73 million shares (16.2% of the float) currently shorted
Current borrow fee: 29.5%
Shares available to borrow: 40'000

47.95% of the daily volume has been shorted on Wednesday but the PPS didn't go down - it seems that the shorts are really getting desperate! Only 40'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 29.5% - as soon as we get some decent volume, the shorts will get a serious problem! Any day from now we might get some more news and the manipulation by the shorts will finally come to an end! And this is all for Multikine, a drug with a median extended life expectancy of more than 4 years and zero toxicity!! Let us hope that many cancer patients can soon profit from this revolutionary treatment! GLTAL! At most 8 days until we get some news from clinicaltrials.gov! Tick tock, tick tock ...

61.58% daily short volume on Monday!

32.53% institutional ownership
61.58% daily short volume on Monday!
6.73 million shares (16.2% of the float) currently shorted
Current borrow fee: 27.8%
Shares available to borrow: 100'000

61.58% of the daily volume has been shorted on Monday - it seems that the shorts are really getting desperate! Only 100'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 27.8% - as soon as we get some decent volume, the shorts will get a serious problem! Any day from now we might get some more news and the manipulation by the shorts will finally come to an end! And this is all for Multikine, a drug with a median extended life expectancy of more than 4 years and zero toxicity!! Let us hope that many cancer patients can soon profit from this revolutionary treatment! GLTAL! At most 10 days until we get some news from clinicaltrials.gov! Tick tock, tick tock ...

35.55% daily short volume today but PPS went up 5.25%!

33.28% institutional ownership
35.55% daily short volume today!
6.73 million shares (16.2% of the float) currently shorted
Current borrow fee: 31.1%
Shares available to borrow: 250'000

35.55% of the daily volume has been shorted today but the PPS went up 5.25%! Only 250'000 shares are currently available for shorting (iborrowdesk) and the borrow fee is 31.1% - as soon as we get some decent volume, the shorts will get a serious problem! Any day from now we might get some more news and the manipulation by the shorts will finally come to an end! And this is all for a drug with a median extended life expectancy of more than 4 years and zero toxicity!! Let us hope that many cancer patients can soon profit from this revolutionary treatment! GLTAL! At most 12 days until we get some news from clinicaltrials.gov! Tick tock, tick tock ...